Vimarsana
Biggest News Aggregation in the World

Page 3 - Executive Albert Bourla News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Executive Albert Bourla. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Executive Albert Bourla Today - Breaking & Trending Today

Pfizer Sees Steep 2023 Fall in COVID Sales, Aims to Bolster Pipeline - Vimarsana News

Pfizer Sees Steep 2023 Fall in COVID Sales, Aims to Bolster Pipeline

Pfizer on Tuesday forecast a bigger-than-expected drop in sales of its COVID-19 vaccine and treatment for 2023, intensifying investor concerns over demand for the products as governments cut orders and work through inventories.

Pfizer Forecasts Steep Fall In 2023 Sales Of COVID Products - Vimarsana News

Pfizer Forecasts Steep Fall In 2023 Sales Of COVID Products

Pfizer Inc on Tuesday forecast a bigger-than-expected drop in sales of its COVID-19 vaccine and treatment in 2023, intensifying investor concerns over demand for the products as governments cut

Reuters Health News Summary - Vimarsana News

Reuters Health News Summary

Prime Minister Han Duck-soo said Seoul could consider lifting the limit on short-term visas for such travellers before the end of February if China's tally of COVID infections proved manageable, the Yonhap news agency said. WHO maintains highest alert over COVID, but sees hope ahead The World Health Organization (WHO) said on Monday that COVID-19 continues to constitute a public health emergency of international concern, its highest form of alert.

Pfizer forecasts steep fall in 2023 sales of COVID products - Vimarsana News

Pfizer forecasts steep fall in 2023 sales of COVID products

Pfizer Inc on Tuesday forecasted a bigger than expected drop in sales of its COVID 19 vaccine and treatment for 2023, intensifying investor concerns o...

Pfizer to sell all its patented drugs at nonprofit price in low-income countries - Vimarsana News

Pfizer to sell all its patented drugs at nonprofit price in low-income countries

Pfizer Inc will make all of its patented medicines available at a not-for-profit price to 45 of the world's poorest countries